{"title":"A Comprehensive Review of Current and Future Perspectives of Micro and Nano Robot Technology and Its Applications in the Medical Field.","authors":"Ubaidulla Uthumansha, Sandhiya Vaithi, Kousalya Prabahar, Nehal Elsherbiny, Mona Qushawy","doi":"10.2174/0118722105399443251201131349","DOIUrl":"https://doi.org/10.2174/0118722105399443251201131349","url":null,"abstract":"<p><p>Micro- and nanorobots are rapidly emerging as innovative tools in biomedicine, capable of performing highly localized tasks such as targeted drug delivery, minimally invasive diagnostics, and microscale surgical procedures. A notable shift over the past decade has been the evolution from rigid, hard-structured devices to soft, flexible micro- and nanorobots. This transition enables better adaptability within complex biological environments and enhances biocompatibility, paving the way for more effective and safer in vivo applications. Recent research has emphasized the fabrication of soft micro- and nanorobotic components, including actuators, sensors, hinges, joints, and drug reservoirs. Inspired by the locomotion mechanisms of flexible microorganisms, these components have been designed to mimic natural motion. The integration of organic and stimuli-responsive materials, such as polymers and supramolecular ensembles, has further enabled these systems to undergo complex behaviors, including dynamic shape transformations and advanced propulsion strategies. Additionally, biological entities, such as contractile mammalian cells and microorganisms, have been harnessed as microengines, driving motion by inducing deformation in synthetic materials. These biohybrid designs represent a significant advancement in the functionality and versatility of microand nanoswimmers. Recent advancements have introduced the concept of Collectives of Nanorobots (CNRs), expanding the functional scope of these systems for medical applications. These collectives have demonstrated potential in a range of critical tasks, including (a) mapping anatomical structures, (b) regulating cardiovascular function, (c) managing glucose and insulin levels, (d) executing precise drug delivery, (e) diagnosing cellular abnormalities, and (f) selectively targeting and eliminating tumor cells. This review highlights the diverse architectures, patented technologies, and actuation mechanisms that underpin the operation of soft micro- and nanorobots. By examining their motion dynamics and clinical utility, this work underscores the transformative potential of these devices in next-generation medical interventions.</p>","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"20 4","pages":"339-354"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Emerging Materials and Nanostructures for Multifunctional Nanocarriers: Innovations and Patented Advances in Targeted Drug Delivery.","authors":"Dilpreet Singh","doi":"10.2174/0118722105376511250206104648","DOIUrl":"https://doi.org/10.2174/0118722105376511250206104648","url":null,"abstract":"","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"20 4","pages":"293-296"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Patent Landscape of Co-Amorphous Drug Formulations (1993-2025): Comparative Analysis Across the US, China, Japan, Australia and Insights for R&D & IP Management.","authors":"Pawan Deviprasad, Belapu Skanda Rao, Virendra Ligade, Ravi Gundawar, Sachin Dattram Pawar","doi":"10.2174/0118722105417828260216044945","DOIUrl":"https://doi.org/10.2174/0118722105417828260216044945","url":null,"abstract":"<p><strong>Introduction: </strong>A co-amorphous substance is a new drug-delivery technology for pharmaceutical formulations that consists of a homogeneous, single-phase mixture of two or more lowmolecular- weight molecules. Such systems have the potential to improve the dissolution rate, solubility, and bioavailability of poorly water-soluble drugs. Additionally, they provide greater physical stability than the crystalline and amorphous forms of the same drug.</p><p><strong>Methods: </strong>This study employed systematic patent landscape analysis regarding the development of co-amorphous material systems. It contains information from 10 projects, compiled in Microsoft Excel, and records patent submissions compiled from 1993 through early 2025, covering the four major countries USA, China, Japan, and Australia. These Patents landscape provides information on granted patents and applications by applicant name and number, filing and publication dates, and publication type (A1/B2).</p><p><strong>Results: </strong>The patent landscape analysis shows that patent applications increased in both the US and China post-2020. In Japan, there was a more equal distribution of patents between industry and academia than in Australia, where many patents were filed by industry. The primary applicants for these patents include Zerion Pharma APS and MSN Laboratories. These patents provide information on the application of \"Co-Amorphous Technology\" within both the nutraceutical and agrochemical industries.</p><p><strong>Discussion: </strong>The increase in the patent growth trends indicated increasing recognition of coamorphous systems to enhance drug performance. The geographic distribution highlighted different models of innovation, from academia-industry collaborations to industry-dominated research. The participation of leading pharmaceutical companies further marked the commercial feasibility of such systems.</p><p><strong>Conclusion: </strong>This patent landscape analysis provides essential information on innovation trends in co-amorphous systems. This information can be used for planning in the pharmaceutical research and technology development fields.</p>","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"20 4","pages":"355-369"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Management of Dermatological Manifestations of PCOS: Currently Used Drugs in Medical Therapy and Cosmetic/Local Therapy","authors":"Syed Douhath Yousuf, Mohammad Ashraf Ganie","doi":"10.2174/9798898810962125010008","DOIUrl":"https://doi.org/10.2174/9798898810962125010008","url":null,"abstract":"Due to hyperandrogenism, dermatological manifestations are common in PCOS, which include acne, hirsutism, alopecia, hyperpigmentation, seborrhea, skin tags, and milia. These dermatological symptoms can significantly impact the quality of life and self-esteem of affected individuals. Therefore, effective management strategies are essential to address these concerns comprehensively. This chapter aims to provide a comprehensive overview of the management of dermatological symptoms associated with PCOS. It discusses the various treatment modalities that are reviewed, including topical agents, oral medications, cosmetic procedures, and laser therapy.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"48-62"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147887188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Current Available Pharmacological Intervention for PCOS-III","authors":"Yasmeena Quadir, Yasmeena Sultan, Rohina Bashir, Rabia Hamid, Mohammad Ashraf Ganie","doi":"10.2174/9798898810962125010007","DOIUrl":"https://doi.org/10.2174/9798898810962125010007","url":null,"abstract":"Anti-androgens function to ameliorate symptomatic manifestations associated with hyperandrogenism in PCOS, thereby addressing a cornerstone aspect of the condition's pathophysiology. Chemically, antiandrogens are classified into steroidal (such as spironolactone and cyproterone acetate) and nonsteroidal (including flutamide, nilutamide, and bicalutamide). Through their antagonistic action on androgen receptors or inhibition of androgen synthesis, antiandrogens mitigate hirsutism, acne, and alopecia, thereby improving the quality of life and psychological well-being of PCOS women. Additionally, studies have highlighted the profound implications of hyperandrogenism on crucial aspects of reproductive physiology, including ovulation dynamics, reduced pregnancy rates, risk of preterm delivery, and susceptibility to preeclampsia, culminating in diminished rates of live births. Consequently, there is a compelling rationale to consider that the incorporation of anti-androgen therapy may hold promise in augmenting fertility outcomes within this patient cohort.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"36-47"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147915339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shafia Bashir, Insha Mushtaq Shah, Bazila Ashraf, Mohammad Ishaq Geer, Mohammad Ashraf Ganie
{"title":"Current Available Pharmacological Interventions for PCOS: Oral Contraceptive Pills","authors":"Shafia Bashir, Insha Mushtaq Shah, Bazila Ashraf, Mohammad Ishaq Geer, Mohammad Ashraf Ganie","doi":"10.2174/9798898810962125010005","DOIUrl":"https://doi.org/10.2174/9798898810962125010005","url":null,"abstract":"Hormonal contraceptives, progestins, and metformin are some of the most often prescribed treatments for PCOS. Ovulation induction therapies, which may include medications like Letrozole, Clomiphene, or Gonadotropin therapy, are the mainstay of infertility treatment. Hormonal contraceptives and adjuvant anti-androgen therapy are frequently used to treat hirsutism. Women with Polycystic Ovarian Syndrome (PCOS) are frequently administered Oral Contraceptive Tablets (OCP), which target symptoms like irregular menstrual cycles and clinical hyperandrogenism while simultaneously offering contraception and endometrial protection. In essence, this chapter aims to furnish a comprehensive overview of contemporary research findings pertaining to the utilization of oral contraceptives in managing PCOS. This chapter sheds light on the evolving landscape of PCOS management and the potential avenues offered by oral contraceptive strategies.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"13-23"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147888987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gestational Issues in PCOS","authors":"Cimona Lyn Saldanha","doi":"10.2174/9798898810962125010020","DOIUrl":"https://doi.org/10.2174/9798898810962125010020","url":null,"abstract":"The dysfunctional gonadotropin secretion and other features of PCOS like Insulin Resistance (IR), chronic inflammatory state, and hyperandrogenism have a significant impact on reproductive and gestational outcomes. Women with PCOS have reduced ability to conceive owing to poor oocyte quality, ovulatory dysfunction, implantation failure, and uterine abnormalities. Besides, if the conception stage is crossed, these subjects are at a graded risk of carrying the pregnancy to term and developing various issues like recurrent pregnancy loss, preterm labour, gestational diabetes, and hypertension. This chapter summarises the mechanistic insights into various pregnancy complications and management strategies among PCOS women. Having background knowledge of what and how will help us not only in preparing the optimal management of these women but also put physicians in a position to use preconception counseling as a tool in the armamentarium of prevention of complications of pregnancy and enhance clinical outcomes.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"194-208"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147891306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Presentation of Polycystic Ovary Syndrome","authors":"Shivani Sidana","doi":"10.2174/9798898810931125010009","DOIUrl":"https://doi.org/10.2174/9798898810931125010009","url":null,"abstract":"Clinical presentation of PCOS varies among individuals. A patient with Polycystic Ovary Syndrome (PCOS) may present to the gynecologist with menstrual irregularities, mainly oligo-amenorrhea, by means of detected polycystic morphology on ultrasonography. A patient might also seek a dermatologist for hyperandrogenic manifestations, such as acne, hirsutism, androgenic alopecia, and acanthosis nigricans, or a fertility clinic with complains of infertility. Patients may arrive at the obesity clinic with metabolic abnormalities. Understanding the clinical features at presentation is crucial for understanding the disease and conducting a thorough assessment of the patient. Therefore, in this chapter, we will learn in detail about the assessment of all the clinical features of PCOS in detail. Since PCOS is the diagnosis of exclusion, clinical features differentiating PCOS from other conditions with overlapping symptoms like non-classical congenital adrenal hyperplasia, hypo-hyperthyroidism, hyperprolactinemia, Cushing syndrome, acromegaly, and ovarian and adrenal neoplasm will also be discussed.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"58-71"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147908474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. M. Mangroliya, Hemant Bagul, Parth M. Mangroliya
{"title":"Protected Cultivation of Horticultural Crops: Vegetables and Flowers","authors":"R. M. Mangroliya, Hemant Bagul, Parth M. Mangroliya","doi":"10.2174/9798898810429125010016","DOIUrl":"https://doi.org/10.2174/9798898810429125010016","url":null,"abstract":"Agriculture and other related sectors have a significant impact on the Indian economy. The Green Revolution introduced new biotic and abiotic stresses, posing significant challenges. Protected cultivation minimizes stress by providing a regulated environment. The growing demand for food requires us to consider protected farming. Greenhouses are the most effective solution for protected horticulture. Protected production of high-value vegetables has shown remarkable promise over the past decade. Protected cultivation offers hitherto untapped opportunities in agriculture with the advancement of technology and a liberalized economy. These technologies benefit both large-scale producers and those with smaller landholdings, as increased production levels remain economically relevant to agriculture. Protected cultivation is a precise, progressive, and parallel approach to agriculture that considers technological aspects, grower needs, and market economics. Flowers are becoming popular as a means of celebrating special occasions. India's protected flower industry has led to an increase in commercial flower exports. The meet the demand, floriculture crops like roses, gerbera, carnations, lilies, etc., are grown in protected structures. Protected farming is a crop cultivation technique that controls the plant's microclimate for optimal growth.","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":"1 1","pages":"164-177"},"PeriodicalIF":0.0,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147913789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niko Carstens, Blessing Adejube, Tim Tjardts, Rohit Gupta, Thomas Strunskus, Franz Faupel, Abdou Hassanien, Alexander Vahl
{"title":"Resistive Switching in Nanoparticle-Based Nanocomposites.","authors":"Niko Carstens, Blessing Adejube, Tim Tjardts, Rohit Gupta, Thomas Strunskus, Franz Faupel, Abdou Hassanien, Alexander Vahl","doi":"10.2174/0118722105319247250606185502","DOIUrl":"https://doi.org/10.2174/0118722105319247250606185502","url":null,"abstract":"<p><p>The recent rapid progress in artificial intelligence (AI) and the processing of big data imposes a strong demand to explore novel approaches for robust and efficient hardware solutions. Neuromorphic engineering and brain-inspired electronics take inspiration from biological information pathways in neural assemblies, particularly their fundamental building blocks and organizational principles. In contrast, resistive switching in memristive devices is widely considered an electronic synapse with potential applications in in-memory computing and vector-matrix multiplication. Further aspects of brain-inspired electronics require exploring both organizational principles from individual building units towards connected networks, as well as the resistive switching properties of each unit. In this context, nanogranular matter made of nano-objects, such as nanoparticles or nanowires, has gained considerable research interest due to emergent brain-like, scale-free switching dynamics originating from the self-organization of its building units into connected networks. In this study, we review resistive switching in nanogranular matter featuring metal nanoparticles as their functional building blocks. First, common deposition strategies for nanoparticles, as well as nanoparticle-based nanocomposites, are discussed, and challenges in the investigation of their inherited resistive switching properties are addressed. Secondly, an overview of resistive switching properties in nanogranular matter, ranging from individual nanoparticles over sparse nanoparticle arrangements to highly interconnected nanogranular networks, is provided. Finally, concepts and examples of information processing using nanoparticle networks are outlined.</p>","PeriodicalId":49324,"journal":{"name":"Recent Patents on Nanotechnology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}